![](/CAS/GIF/719285-83-3.gif)
1-(6-Morpholino-2-(2-(Pyridin-2-Yl)Ethoxy)PyriMidin-4-Yl)Hydrazine synthesis
- Product Name:1-(6-Morpholino-2-(2-(Pyridin-2-Yl)Ethoxy)PyriMidin-4-Yl)Hydrazine
- CAS Number:719285-83-3
- Molecular formula:C15H20N6O2
- Molecular Weight:316.36
![4-[6-Chloro-2-(2-(pyridin-2-yl)ethoxy)pyriMidin-4-yl]Morpholine](/CAS/GIF/544693-01-8.gif)
544693-01-8
9 suppliers
$165.00/100mg
![Morpholine, 4-[2-chloro-6-[2-(2-pyridinyl)ethoxy]-4-pyrimidinyl]-](/CAS/20210305/GIF/887402-10-0.gif)
887402-10-0
0 suppliers
inquiry
![Morpholine, 4-[4-chloro-6-[2-(2-pyridinyl)ethoxy]-2-pyrimidinyl]-](/CAS/20210305/GIF/887402-09-7.gif)
887402-09-7
0 suppliers
inquiry
![1-(6-Morpholino-2-(2-(Pyridin-2-Yl)Ethoxy)PyriMidin-4-Yl)Hydrazine](/CAS/GIF/719285-83-3.gif)
719285-83-3
10 suppliers
inquiry
Yield:719285-83-3 73%
Reaction Conditions:
with hydrazine in 1,4-dioxane; for 5 h;Heating / reflux;
Steps:
1.3
Step 3.A stirred suspention of Product 2 (97.4 g, 0.304 mol) and hydrazine monohydrate (53.2 g, 1.06 mol) in dioxane (188 mL) was brought to boil under nitrogen purge, and was re fluxed for 5 hours. Ice water (376 mL) was added to the reaction mixture, and the mixture was allowed to stand overnight. A resulted precipitate was filtered out, washed 3 times with water (260 mL per wash) and vacuum-dried at 40-50 0C until constant weight was maintained to yield Product 3 (70.2 g, 73% yield) as one regioisomer, 2-[2-(pyridin-2-yl)- ethoxy]-4-hydrazino-6-(morpholin-4-yl)-pyrimidme.
References:
WO2006/53112,2006,A1 Location in patent:Page/Page column 52
![4-[6-Chloro-2-(2-(pyridin-2-yl)ethoxy)pyriMidin-4-yl]Morpholine](/CAS/GIF/544693-01-8.gif)
544693-01-8
9 suppliers
$165.00/100mg
![1-(6-Morpholino-2-(2-(Pyridin-2-Yl)Ethoxy)PyriMidin-4-Yl)Hydrazine](/CAS/GIF/719285-83-3.gif)
719285-83-3
10 suppliers
inquiry
![4-(2,6-DICHLOROPYRIMIDIN-4-YL)MORPHOLINE](/CAS/GIF/52127-83-0.gif)
52127-83-0
68 suppliers
$95.00/1g
![1-(6-Morpholino-2-(2-(Pyridin-2-Yl)Ethoxy)PyriMidin-4-Yl)Hydrazine](/CAS/GIF/719285-83-3.gif)
719285-83-3
10 suppliers
inquiry